Quality Indicators for Colonoscopy

Slides:



Advertisements
Similar presentations
A Quality Colonoscopy: Are You Providing One?
Advertisements

Colorectal Cancer Screening and Surveillance FDA Advisory Committee March, 2002 David Lieberman MD Chief, Division of Gastroenterology Oregon Health Sciences.
Complications after Colonoscopy and Risk Factors Xinliang “Albert” Liu, PhD Latarsha Chisholm, PhD Department of Health Management and Informatics University.
EQUIP Training session 1
Bowel Preparation Regimens Danielle Goodrich, MSIV University of Maryland School of Medicine.
Multitarget Stool DNA Testing for Colorectal-Cancer Screening NEJM April 3, 2014 Vol 3 Imperiale, T.F. et al Presented by Melissa Spera, MD.

Colorectal Cancer Screening John Pelzel MD Sleepy Eye Medical Center.
Clinical Practice Screening for Colorectal Cancer David A. Lieberman, M.D. N Engl J Med Volume 361(12): September 17, 2009.
Update on Colorectal Cancer Screening Tests Source: Levin Bernard et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous.
Quality Improvement Prepeared By Dr: Manal Moussa.
Benchmarking For Colonoscopy
A CMH Community DocTalk with Robert Wayne, MD, FACS.
Memorial Hermann Healthcare System Clinical Integration & Disease Management Dan Wolterman April 15, 2010.
That is the problem!!!!  Acute colonic pseudo-obstruction (ACPO) is characterised by massive colonic dilation with symptoms and signs of colonic obstruction.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn’s disease or adenomas NICE CG March 2011.
Andreas Adler Charité Medical University of Berlin, Virchow Clinic Campus Central Interdisciplinary Endoscopy Unit Narrow Band versus Conventional Endoscopic.
TREATMENT OF LARGE AND GIANT COLORECTAL POLYPS IN THE REAL WORLD UEGW, PARIS, 2007 Association pour le Dépistage du Cancer colorectal dans le Haut-Rhin.
Colorectal carcinoma Dr.Mohammadzadeh.
COLONIC CLEANSING BEFORE COLON CAPSULE ENDOSCOPY (CCE) – TOLERABLE AND EFFECTIVE? Gábor Balogh MD, András Székely MD, László Madácsy MD PhD Endoscopy Unit,
Perspectives from the Waitemata Bowel Screening Pilot team -The Endoscopic view Paul Frankish Lead Endoscopist.
80% by 2018 Forum: Increasing CRC Screening Rates 80% by 2018 Forum: Increasing CRC Screening Rates Implementing a Quality Screening Navigation Program.
Standard 10: Preventing Falls and Harm from Falls Accrediting Agencies Surveyor Workshop, 13 August 2012.
Do all colorectal polyps require pathological examination? Aim To assess whether it is possible to omit the pathological examination of some polyps without.
CT Colonography vs Colonoscopy for the Detection of Advanced Neoplasia David H. Kim, M.D., Perry J. Pickhardt, M.D., Andrew J. Taylor, M.D., Winifred K.
High Quality Screening Colonoscopy Colonoscopy is a common endoscopic procedure, with more than 3 million examinations performed in the United States annually.
Towards Global Eminence K Y U N G H E E U N I V E R S I T Y Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society.
Quality of Colonoscopy Using an endoscopic database to measure and improve quality AAPCE Memphis- November 5, 2011 David Lieberman MD Chief, Division of.
Moving Toward Universal Colon Cancer Screening: Methods In Unsedated Colonoscopy Christopher Forest, PA-C Darenie Goodman, MD Kelly Jones, MD Wm MacMillan.
Efficient Endoscopic Practice Ryan D. Torrie, MD Taber, AB Canada November 4-5, 2011.
R4 채정민 / Prof 이창균. INTRODUCTION colonoscopy is a widely used screening tool for colorectal cancer adenoma detection rate (ADR) important quality indicator.
CLinical EValuation of the EndoRings: “The CLEVER study” Interim results of a randomized, multicenter, tandem colonoscopy study Introduction Adenomas can.
Am J Gastroenterol 2012; 107:1213– June 2012 R3. 김동희 /prof. 이창균.
High Quality Screening Colonoscopy Colonoscopy is a common endoscopic procedure, with more than 3 million examinations performed in the United States annually.
CLINICAL TRIALS.
FIT Programme (Faecal Immunohistochemical Test)
Cancer prevention and early detection
Governing Body QAPI 2013 Update for ASC
Dr. Kęstutis Adamonis, Dr. Romanas Zykus,
Clinical process indicators
Quality issues in monitoring diagnostic and treatment performance Dr
Chapter 33 Introduction to the Nursing Process
Colorectal Cancer Screening Guidelines
BOWEL SCOPE SCREENING Dorset BCSP
Performance indicators in CRC screening program
The addition of histology to continuous audit has significantly increased adenoma detection rate in a private endoscopy unit AG Fraser 1, GD Gamble 1,
27th Annual Winter CME Conference
Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.
Sessile Serrated Adenomas: An Evidence-Based Guide to Management
Full-Spectrum Endoscopy Improves Adenoma Detection Compared to Conventional Colonoscopy PLUS Right-Colon Examination With Scope Retroflexion: A Randomized,
Repeat Colonoscopy Recommendations
A Visual Tour of Effective Colonoscopy
Common indicators related to organization and invitation
The Nursing Process and Pharmacology Jeanelle F. Jimenez RN, BSN, CCRN
Improving Quality Measures for Colonoscopy and CRC Prevention
Overview: Understanding and Building a Schoolwide Assessment Plan
Feeling Rushed? Does Late Start Time Predict Poor Quality Colonoscopy?
Clinical audit 2017/18 National Results
Sessile Serrated Adenomas: An Evidence-Based Guide to Management
Clinical audit 2017/18 National Results
Polyps of the Colon and Rectum
Making MDTs better Steve Falk
VIRTUAL COLONOSCOPY DR DEEPIKA SOLANKI.
A Visual Tour of Effective Colonoscopy
Reporting in CRC screening
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
Risks of interval colorectal cancer in a FIT-based screening program
Colonoscopy in crc screening
Presentation transcript:

Quality Indicators for Colonoscopy Dr. Kęstutis Adamonis, Dr. Romanas Zykus, 2017 02 15 – 22 2017 03 09 – 15

Colonoscopy The invention of the colonoscope has revolutionized the way we evaluate luminal diseases of the colon. With colorectal cancer being the third most commonly diagnosed cancer as well as the third most frequent cause of cancer-related mortality in both men and women, colonoscopy offers an advantage of detecting cancer and the ability to remove precancerous lesions. As a result of its effectiveness in the detection and prevention of colorectal neoplasms, colonoscopy has become the screening test of choice for many gastroenterologists and patients

Quality Indicators for Colonoscopy Although the ideal quality measure for colonoscopy is not unequivocally established, there are several proven quality indicators. With most of the problems of colonoscopy resulting from operator-dependent factors, it is no longer acceptable not to measure colonoscopy quality. The judicious use of quality metrics should allow identifying marginal performers and implementing educational initiatives to correct their performance to provide the best care possible to our patients.

Quality Indicators for Colonoscopy Why is this important? To maximize cost-effectiveness of CRC screening with colonoscopy The purpose of colonoscopy is to reduce CRC and improved quality shouldreduce post-colonoscopy or “missed”CRC. To minimize risks to patients

Quality assurance item Proposed standard Consent and withdrawal of consent Audit the number of patients who decline colonoscopy on the day of the procedure and the number of intraprocedural withdrawals of consent. Proposed standard: fewer than 5% of cases to withdraw consent on the day of the procedure and fewer than 1% during the procedure. Experience of the screening colonoscopist We recommend that a minimum lifetime colonoscopy experience together with a minimum number of annual screening colonoscopies should be agreed. Proposed standard: to be agreed by screening boards Bowel cleansing The state of bowel cleansing should be audited. Proposed standard: at least 90% of examinations should be rated as “adequate” bowel cleansing or better Sedation, analgesia, and comfort Audit of sedation practices, including average doses used of medication together with comfort scores. Proposed standard: no more than 1% of patients should become hypoxic (saturation below 85% for more than 30 seconds) or for other reasons require administration of a reversal agent Unadjusted cecal intubation rate Audit the completion rate for all colonoscopies. Proposed standard: unadjusted cecal intubation rate of at least 90% Adenoma and cancer detection rates The number of detected adenomas and cancers should be audited. Colonoscope withdrawal time Average withdrawal times should be audited. Proposed standard: a minimum of 6 minutes in at least 90% of purely diagnostic examinations Polyp retrieval rate Screening programs anticipate that all resected polyps are retrieved for histological analysis. Proposed standard: ≥ 90% of resected polyps should be retrieved for histological analysis Significant interval lesions We recommend that screening programs monitor size, appearance, location, and histology of all polyps larger than 1 cm and cancers found between screening examinations as well as after the patient has been discharged from a screening program.

Quality assurance item Proposed standard Specialist referral for removal of larger polyps We anticipate that the removal of larger polyps will be deferred to a dedicated clinical session, perhaps at a separate tertiary referral centre. Screening programs should record how larger polyps detected at screening are managed, together with details of outcomes. Proposed standard: to be agreed by screening boards Cleaning and disinfection Adoption of manufacturers’, national, and European standards for disinfection. Proposed standard: routine microbiological testing at intervals not exceeding 3 months Tattooing sites of larger polyps and cancers We recommend that screening programs set standards regarding which polyp sites should be tattooed. Proposed standard: the placement of tattoos following the removal of all polyps 2 cm or larger outside of fixed colonic landmarks such as the cecum and rectum Unscheduled readmissions We recommend that screening programs record details of all emergency admissions within 30 days of the screening colonoscopy. Perforation rate We recommend that details should be recorded of all perforations complicating diagnostic and therapeutic procedures, that require surgical repair and that occur up to 2 weeks after endoscopy. Proposed standard: fewer than 1:1000 diagnostic or therapeutic examinations should result in a perforation requiring surgical repair Bleeding rate All cases of immediate and late bleeding following polypectomy should be recorded. Proposed standard: fewer than 1:20 cases of bleeding should ultimately require surgical intervention

Most important QIC indicators Adenoma detection rate Cecal intubation rate Endoscopic complication rate Colonoscopist patient load Quality of colonoscopy preparation Colonoscope withdrawal time Left and right colon adenoma detection proportion Mean adenomas per procedure Sessile serrated lesion in right colon detection rate Referral to surgery or tertiary endoscopy in the same or another center

Adenoma detection rate Adenoma detection rate(ADR), the primary quality indicator or outcome for an endoscopist, can be viewed as a function of the other quality measures. These include cecal intubation rates, withdrawal times, and quality of bowel preparations.

Performance of endoscopists It is recommended that the annual number of procedures performed by an endoscopist is recorded to ensure that the sample size for key performance indicators is sufficient Each endoscopist participating in a colorectal cancer screening programme should undertake to perform at least 300 procedures per year to ensure there is a sufficient sample size to assess competence. A higher volume of procedures is desirable Services should be planned such that individual endoscopists achieve a desirable volume of procedures (>300/ year)

Bowel preparation quality Another quality measure that affects adenoma detection is the quality of the bowel preparation. An adequate colon preparation is vital to ensure complete mucosal inspection. It has been reported that only three quarter of colonoscopies have an adequate colon preparation. High rates of missed adenomas and advanced neoplasia have been observed in patients with suboptimal colon preparations.

Boston bowel preparation score is the most popular validated score

Representative photos of bowel segments scored using the Boston Bowel Preparation Scale (a) Segment score 0: unprepared colon segment with the visibility of the mucosa obscured by solid stool material that cannot be cleared. (b) Segment score 1: poorly prepared colon segment in which only limited portions of mucosa can be seen, while other areas of the colon segment are obscured by staining, residual stool, and/or opaque liquid. (c) Segment score 2: minor amount of residual staining, small fragments of stool and/or opaque liquid that are sufficiently reduced as to allow the mucosa of the colon segment to be seen. (d) Segment score 3: a colon segment in which the entire mucosa can be seen well with no residual staining, small fragments of stool, or opaque liquid.

Bowel Preparation is Adequate: 90% of Outpatient Procedures Frequency of inadequate bowel preparation that requires repeat colonoscopy within 1 year should be < 10%. If this goal isn’t met, then bowel preparation protocols, including patient education, choice of purgative, and protocol for administering the purgative, including use of the split-dose protocol, should be re-examined. Goal: Minimize need to repeat colonoscopy.

Bowel Preparation is Adequate: 90% of Outpatient Procedures What interventions may minimize inadequate bowel preps: Institute split-bowel preparation. Ingesting the 2nd half of bowel preparation 6 hours prior to colonoscopy is optimal Use more aggressive bowel preparation regimens for patients at high risk for inadequate preparation (e.g., history of constipation, diabetic, opiod-use, history of poor bowel prep in the past).

Colonoscope withdrawal time To maximize adenoma detection, adequate mucosal inspection is required to ensure complete examination Withdrawal time, the time measured from when the colonoscope reaches the cecum to the time the scope is withdrawn from the anus in the absence of polyp removal, has also been studied as a quality metric in colonoscopy.

Colonoscope withdrawal time Studies have demonstrated that a withdrawal time of ≥6 min or more increased the detection of neoplastic lesions during colonoscopy in patients with intact colons. The investigators observed that compared with endoscopists who had mean withdrawal times of 6 min or longer, those who had a shorter withdrawal time had lower detection rates of any adenoma as well as advanced adenomas.

Colonoscope withdrawal time Longer withdrawal time was recently reported to be associated with higher proximal serrated polyp detection rate (PSP-DR) significant increase of the ADR. Withdrawal time could have a role for endoscopists not meeting targets for ADR, PR, and PSP-DR. Recommendation - its use in instances of low ADR.

Retrieval of polyps The risk of polyp-cancer increases with the size of the polyp In the UK pilot demonstration of colorectal screening, 16.6% of all cancers were “polyp cancers” In organized screening programs it is expected that resected polyps will be retrieved for histological analysis Successful retrieval of at least 90% of excised polypsseems a reasonable standard

Proximal Serrated Polyp Detection Rate Proximal serrated polyp detection rate (PSP-DR) is defined as the proportion of patients undergoing screening colonoscopy in whom at least one serrated polyp (hyperplastic polyp, sessile serrated adenoma/polyp, traditional serrated adenoma) is identified proximal to the splenic flexure. Interest in the PSP-DR has been rising in relation to the concerns about the limited protective effect of colonoscopy in the right colon and the emerging appreciation of the role of the serrated pathway in colorectal neoplasia. Potential contributing factors are : the more subtle endoscopic features of serrated polyps and the lower quality of bowel preparation in the right colon, particularly without split dosing.

Proximal Serrated Polyp Detection Rate The strong correlation between ADR and PSP-DR suggests that PSP-DR can be considered a valid measure of quality for colonoscopy. However, the strong correlation also implies redundancy between ADR and PSP-DR. There are other obstacles to the PSP-DR becoming an independent quality metric. The current targets for ADR have been shown to correspond to PSP-DR of 4.5% for both men and women, with a suggested benchmark of 5%. The ADR can be used as surrogate for both adenomatous and serrated polyps, but high-level adenoma detectors who are motivated to obtain a comprehensive assessment of quality can consider measuring PSP-DR as a complementary quality metric

The mean number of adenomas per colonoscopy Adenoma detection rate (ADR) is most commonly recommended neoplasia – related quality indicator. However, the mean number of adenomas (MNA) per colonoscopy is better reflection full length of colon examination and “could prove“ to be the ideal measure of adenoma detection. Assesses the ability of endoscopists in detecting multiple adenomas per patient. MNA is sensitive to changes in bowel preparation with higher MNA among those with good bowel preparation compared with those with poor preparation.

Left and right colon adenoma detection proportion Share of adenomas detected in left/ right colon among all adenomas detected in entire colon. Right hemicolon includes flexura lienalis, colon transversum flexura hepatica, colon ascendens, and cecum. Left hemicolon includes anus, rectum, colon sigmoideum and colon descendens.

Referral to surgery or tertiary endoscopy in the same or another center Share of people referred to surgery or additional colonoscopy for polypectomy among number of people with findings at colonoscopy It is recommended that screening programs audit how larger lesions detected at screening are managed, together with details of outcomes (In particular, the number of benign lesions referred for surgical resection should be recorded and outcomes monitored) There is evidence from the French screening program that up to 10% of entirely benign polyps are removed surgically rather than endoscopically.

**What Are the Quality Indicators? Quality Indicators that should be met in > 98% of colonoscopies: Informed consent is documented. Quality of bowel preparation is reported. Withdrawal time is measured and reported. Endoscopic removal of pedunculated polyps and large (< 2cm) sessile polyps should be attempted before surgical referral.

**What Are the Quality Indicators? Documented Appropriate Indication for Colonoscopy: > 80% Bowel preparation is adequate: 90% Cecal intubation: >95% Average withdrawal time in negative screening colonoscopies: >6 minutes

Workshop: Quality indicators for colonoscopy You are the leader of Hospital endoscopy staff. You got the report from “National Committee for organization, expert monitoring, evaluation and quality control of the National colorectal cancer screening programme” indicating that the average quantity of interval cancers is higher than in other hospitals.

Discussion What group of indicators should be checked for the reason of failure? What results could show all these indicators? Why quality of colonoscopy indicators are important to staff leader and witch of these indicators should be check first? At what level and cross-section all these indicators should be checked, why? (staff in general, separate colonoscopist) Who is responsible for input of the data required for these indicators? Is there any problem to monitor these indicators in Croatia? (At doctor, staff, hospital, county and country level). Who is most interested in gathering this data (medical workers, public health specialist, government or health system insurance?) What materials and resources are needed to monitor all these indicators and to improve its collection?